Share

BIOSQIN

3D Bioprinting of human skin and squamous cell tumors as advanced models for precision medicine 

Project objectives

The BIOSQIN project intends to develop, validate and disseminate the use - among companies in the pharmaceutical and biomedical sector widely represented in the entrepreneurial fabric of the Lazio Region - of a 3D model of human skin and squamous cell carcinoma (SCC) obtained through bioprinting (3D bioprinting). This advanced, physiologically relevant model will be used to identify and characterize new tumor-specific drugs and to evaluate their efficacy or toxicity. > Project site

Start and end date

April 2022 – November 2023

Project Manager

Sara Maria Giannitelli, Head of Unit

Coordinating institution of the project

Higher Institute of Health ISS

Other Institutions involved

IRCCS Dermopathic Institute of the Immaculate Conception (IDI-IRCCS)

Funding source(s).

Regional Funds POR-FESR Lazio 2014/2020, "Research Groups 2020"

 

 

magnifiercrossmenuchevron-downchevron-leftchevron-right